Horizon Pharma Plc (HZNP)

13.96
0.13 0.92
NASDAQ : Health Technology
Prev Close 14.09
Open 14.15
Day Low/High 13.96 / 14.28
52 Wk Low/High 9.45 / 17.69
Volume 3.24M
Avg Volume 1.74M
Exchange NASDAQ
Shares Outstanding 163.89M
Market Cap 2.28B
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

While Donald Trump's tweets can shake up pharmaceutical stocks, history suggests that investors have little to fear from the president's drug pricing rhetoric.

Horizon Pharma Plc Announces Agreement To License Pre-Clinical Uricase Derivative (MEDI4945) From MedImmune

Horizon Pharma Plc Announces Agreement To License Pre-Clinical Uricase Derivative (MEDI4945) From MedImmune

Agreement Aims to Further Expand Growing Gout Franchise 

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

The Dublin firm on Nov. 6 unveiled third-quarter numbers that topped analysts' estimates and raised its full-year net sales outlook and the lower end of its 2017 adjusted Ebitda guidance.

Roku, Nucana and Other IPOs That Should Be on Your Radar in 2017

Roku, Nucana and Other IPOs That Should Be on Your Radar in 2017

Newly public companies such as Roku, NuCana and Restoration Robotics could bring a jolt to your portfolio. But remember all IPOs aren't created equally.

TheStreet Quant Rating: D (Sell)